Authors

• Melinda Gooderham (ORCID: https://orcid.org/0000-0001-8926-0113)
• J.Q. Del Rosso (ORCID: https://orcid.org/0000-0003-4215-7340)
• Kim Papp (ORCID: https://orcid.org/0000-0001-9557-3642)
• Robert Higham
• Patrick Burnett (ORCID: https://orcid.org/0000-0002-7123-9161)
• Mark Lebwohl (ORCID: https://orcid.org/0000-0002-4705-5303)
• Linda Stein Gold (ORCID: https://orcid.org/0000-0002-2758-1605)
• Leon Kircik (ORCID: https://orcid.org/0000-0002-0831-2151)
• Hwanhee Hong (ORCID: https://orcid.org/0000-0002-3736-6327)
• Melissa S. Seal
• David M. Pariser (ORCID: https://orcid.org/0000-0003-2250-9361)
• Adelaide A. Hebert (ORCID: https://orcid.org/0000-0002-9167-5729)
• Bruce E Strober (ORCID: https://orcid.org/0000-0002-8394-2057)
• David H. Chu (ORCID: https://orcid.org/0000-0001-7797-3829)
• David R. Berk
• David Krupa

Institutions

• University of British Columbia (CA)
• Eastern Virginia Medical School (US)
• University of Toronto (CA)
• Queen's University (CA)
• Indianapolis Zoo (US)
• Henry Ford Hospital (US)
• Yale University (US)
• SKiN Health (CA)
• Probity Medical Research (CA)
• Atara Biotherapeutics (United States) (US)
• Indiana University – Purdue University Indianapolis (US)
• Trent University (CA)
• The University of Texas Health Science Center at Houston (US)
• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

Dermatology and Therapy

Published

2025-10-24

DOI

https://doi.org/10.1007/s13555-025-01562-4

Primary Topic

Psoriasis: Treatment and Pathogenesis

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Amgen
• Eli Lilly and Company
• Pfizer
• Sanofi
• Celgene
• Helsinn
• Regeneron Pharmaceuticals
• Valeant Pharmaceuticals International
• Dermira
• Incyte
• Celltrion
• Ortho Dermatologics
• Castle Biosciences
• Meiji Seika Pharma
• Galderma
• Sun Pharma
• Bausch Health
• LEO Pharma
• Helsinn Therapeutics
• Sanofi Genzyme